These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
870 related articles for article (PubMed ID: 13129991)
21. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812 [TBL] [Abstract][Full Text] [Related]
22. The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate. Smith P; Bullock JM; Booker BM; Haas CE; Berenson CS; Jusko WJ Pharmacotherapy; 2004 Nov; 24(11):1508-14. PubMed ID: 15537555 [TBL] [Abstract][Full Text] [Related]
23. The influence of St John's Wort on CYP2C19 activity with respect to genotype. Wang LS; Zhu B; Abd El-Aty AM; Zhou G; Li Z; Wu J; Chen GL; Liu J; Tang ZR; An W; Li Q; Wang D; Zhou HH J Clin Pharmacol; 2004 Jun; 44(6):577-81. PubMed ID: 15145964 [TBL] [Abstract][Full Text] [Related]
24. St John's wort greatly decreases the plasma concentrations of oral S-ketamine. Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Neuvonen PJ; Olkkola KT Fundam Clin Pharmacol; 2012 Dec; 26(6):743-50. PubMed ID: 21635359 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers. Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450 [TBL] [Abstract][Full Text] [Related]
26. Effect of St John's wort on the pharmacokinetics of fexofenadine. Wang Z; Hamman MA; Huang SM; Lesko LJ; Hall SD Clin Pharmacol Ther; 2002 Jun; 71(6):414-20. PubMed ID: 12087344 [TBL] [Abstract][Full Text] [Related]
27. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. Markowitz JS; Donovan JL; Lindsay DeVane C; Sipkes L; Chavin KD J Clin Psychopharmacol; 2003 Dec; 23(6):576-81. PubMed ID: 14624188 [TBL] [Abstract][Full Text] [Related]
28. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY Drugs Aging; 2005; 22(6):525-39. PubMed ID: 15974642 [TBL] [Abstract][Full Text] [Related]
29. Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity. Fuchs I; Hafner-Blumenstiel V; Markert C; Burhenne J; Weiss J; Haefeli WE; Mikus G Eur J Clin Pharmacol; 2013 Mar; 69(3):507-13. PubMed ID: 22968811 [TBL] [Abstract][Full Text] [Related]
30. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers. Burstein AH; Horton RL; Dunn T; Alfaro RM; Piscitelli SC; Theodore W Clin Pharmacol Ther; 2000 Dec; 68(6):605-12. PubMed ID: 11180020 [TBL] [Abstract][Full Text] [Related]
31. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Sugimoto K; Ohmori M; Tsuruoka S; Nishiki K; Kawaguchi A; Harada K; Arakawa M; Sakamoto K; Masada M; Miyamori I; Fujimura A Clin Pharmacol Ther; 2001 Dec; 70(6):518-24. PubMed ID: 11753267 [TBL] [Abstract][Full Text] [Related]
32. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Xu H; Williams KM; Liauw WS; Murray M; Day RO; McLachlan AJ Br J Pharmacol; 2008 Apr; 153(7):1579-86. PubMed ID: 18204476 [TBL] [Abstract][Full Text] [Related]
33. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Donovan JL; DeVane CL; Chavin KD; Wang JS; Gibson BB; Gefroh HA; Markowitz JS Drug Metab Dispos; 2004 Dec; 32(12):1333-6. PubMed ID: 15328251 [TBL] [Abstract][Full Text] [Related]
34. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377 [TBL] [Abstract][Full Text] [Related]
35. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract. Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409 [TBL] [Abstract][Full Text] [Related]
36. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Markowitz JS; Devane CL; Chavin KD; Taylor RM; Ruan Y; Donovan JL Clin Pharmacol Ther; 2003 Aug; 74(2):170-7. PubMed ID: 12891227 [TBL] [Abstract][Full Text] [Related]
37. Drug interaction between St. John's wort and cyclosporine. Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR Ann Pharmacother; 2000 Sep; 34(9):1013-6. PubMed ID: 10981246 [TBL] [Abstract][Full Text] [Related]
38. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346 [TBL] [Abstract][Full Text] [Related]
39. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961 [TBL] [Abstract][Full Text] [Related]
40. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures. Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]